The application of modern molecular biological and genetic techniques to the study of acquired and inherited human diseases has provided new insights into the role of ion channel mutations in a wide variety of human diseases (ion channelopathies). Although defects in anion (chloride) channels have been definitively linked to human diseases such as cystic fibrosis, generalized myotonias, Batter Syndrome and recessive nephrolithiasis, the possible role of ion channelopathies in cardiovascular disease has been mostly limited to the consideration of cation channel defects, and the role of anion channels in many types of cardiovascular disease has not yet been systematically investigated. The long term objective of this Center of Biomedical Research Excellence (COBRE) application is to advance our present understanding of the molecular and biophysical properties of anion channels and their regulation in the cardiovascular system, and determine their role in human cardiovascular disease, using complementary experimental approaches that include well- defined animal disease models, transgenic mice, and human molecular genetics. The proposed COBRE represents a comprehensive, multi- disciplinary effort involving the coordination and integration of five separate, but closely related, research projects, supported by three core facilities. This COBRE program offers a variety of unique opportunities: (1) to advance knowledge regarding the role of anion channelopathies in cardiovascular disease, (2) to support and promote the development of a cadre of young biomedical research investigators at the University of Nevada, (3) to promote the expansion of an existing, unique, NIH-funded biomedical research program, and (4) to promote the development of new, state-of-the-art transgenic, genomic and molecular genetic resources at the University of Nevada School of Medicine.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Exploratory Grants (P20)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-RCMI-2 (02))
Program Officer
Liu, Yanping
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Nevada Reno
Schools of Medicine
United States
Zip Code
Ba, Mariam A; Surina, Jeffrey; Singer, Cherie A et al. (2017) Knockdown of subunit 3 of the COP9 signalosome inhibits C2C12 myoblast differentiation via NF-KappaB signaling pathway. BMC Pharmacol Toxicol 18:47
Duan, Dayue Darrel (2013) Phenomics of cardiac chloride channels. Compr Physiol 3:667-92
Forrest, Abigail S; Joyce, Talia C; Huebner, Marissa L et al. (2012) Increased TMEM16A-encoded calcium-activated chloride channel activity is associated with pulmonary hypertension. Am J Physiol Cell Physiol 303:C1229-43
von Bartheld, Christopher S (2012) Distribution of Particles in the Z-axis of Tissue Sections: Relevance for Counting Methods. Neuroquantology 10:66-75
Angermann, Jeff E; Forrest, Abigail S; Greenwood, Iain A et al. (2012) Activation of Ca2+-activated Cl- channels by store-operated Ca2+ entry in arterial smooth muscle cells does not require reverse-mode Na+/Ca2+ exchange. Can J Physiol Pharmacol 90:903-21
Li, Chuanwei; Pei, Fang; Zhu, Xiaoshan et al. (2012) Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction. Clin Biochem 45:727-32
Wiggins, Larisa M; Kuta, A; Stevens, James C et al. (2012) A novel phenotype for the dynein heavy chain mutation Loa: altered dendritic morphology, organelle density, and reduced numbers of trigeminal motoneurons. J Comp Neurol 520:2757-73
Duan, Dayue Darrel (2011) The ClC-3 chloride channels in cardiovascular disease. Acta Pharmacol Sin 32:675-84
He, Xuyu; Gao, Xiuren; Peng, Longyun et al. (2011) Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ Res 108:164-75
Xiang, Sunny Yang; Ye, Linda L; Duan, Li-lu Marie et al. (2011) Characterization of a critical role for CFTR chloride channels in cardioprotection against ischemia/reperfusion injury. Acta Pharmacol Sin 32:824-33

Showing the most recent 10 out of 77 publications